Solta Medical Ships One Millionth Tip for Thermage and Frax... ( HAYWARD Calif. Dec. 16 2010 /- Solta ...)

Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices

Date:12/16/2010

HAYWARD, Calif., Dec. 16, 2010 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has shipped its one millionth tip for the revolutionary Thermage and Fraxel devices that have helped to build the foundation of Solta Medical and transform the aesthetic medical device industry.

The milestone reflects how much the aesthetic medical device industry has changed in the past decade. The introduction of non-invasive devices like the Thermage's radiofrequency technology system in 2002 and Fraxel's fractional resurfacing laser in 2004 gave physicians popular, new options that provided patients effective results without the risks and downtime associated with surgery.

"The shipment of our millionth tip represents another important milestone for Solta Medical. With this achievement, Solta has demonstrated once again its leadership position in the market through the growing acceptance of our Thermage and Fraxel product lines," said Stephen J. Fanning, Chairman of the Board, president and CEO of Solta Medical, Inc. "We see other unmet needs in the aesthetic treatment continuum and we will continue to introduce new, safe, innovative anti-aging solutions to deliver the best possible results with non-invasive aesthetic treatments."

"Solta helped to transform aesthetic devices - with its deep roots in rigorous science - providing state-of-the-art technologies used to treat patients who sought effective, comfortable therapies," said Roy G. Geronemus, MD, Director of the Laser & Skin Surgery Center of New York. "There was a large patient base that sought more effective solutions than they could get from topical treatments but were either concerned about the cost or downtime associated with surgical procedures. Solta
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Solta Medical Reports Third Quarter 2010 Results
2. Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
3. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
4. Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call
5. Solta Medical Announces Thermage CPT™ and Fraxel re:store® Dual Systems Receive Health Canada Approval
6. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
7. Solta Medical and Alma Lasers Resolve Patent Lawsuits
8. Solta Medical to Participate in 2nd Annual Lazard Capital Markets Medical Technology Conference
9. Solta Medical, Inc. Announces Fourth Quarter 2009 Results Release Date and Conference Call
10. Solta Medical Donates Fraxel re:store(R) Laser System to Grossman Burn Foundation
11. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market

Post Your Comments:

(Date:5/24/2013)... 24, 2013 China Biologic Products, Inc. (Nasdaq: ... integrated plasma-based biopharmaceutical company in China ... from a public announcement issued by Shanghai RAAS Blood ... on Shenzhen Stock Exchange, that on May 21, 2013, ... Chan"), one of the shareholders of the Company, and ...

(Date:5/24/2013)... The potential of the pulmonary ... therapeutic agents has been receiving undeniable attention with the ... promise. The crucial formulation considerations for orally inhaled products ... major role in the efficiency of pulmonary delivery, and ... new formulation techniques and devices in recent years. ...

(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...

Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2 China Biologic Comments on the Proposed Shanghai RAAS Transaction 3 China Biologic Comments on the Proposed Shanghai RAAS Transaction 4 Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] China Biologic Comments on the Proposed Shanghai RAAS Transaction [0] Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2

... (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for ... Key Recent Highlights: Announced positive ... 2 study of Arikace™ (liposomal amikacin for inhalation) in the ... lung infections Added to Russell 3000, Russell 2000, ...

... Systech International®, the recognized global leader in Serialization and ... and manufacturing optimization services company, today announced that VCG ... in Puerto Rico. VCG now has the ability to ... customer-base in region. "We are thrilled ...

Cached Medicine Technology:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 2 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 3 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 4 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 5 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 6 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 7 Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 8 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011 Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico

(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...

(Date:5/25/2013)... Ayurveda is the traditional medicine ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... believes that in order to re-establish optimal health, we must ... adopt a life style which brings us back into harmony. ...

(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...

(Date:5/25/2013)... http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , Resource4thePeople is ... of a jury's award of $6.5 million in damages ... the country over allegations that the diabetes drug Actos ... The judge in the case ruled that the man's ... was caused by the medication.** , Bloomberg News in ...

(Date:5/25/2013)... 25, 2013 AdvantaClean of Pikes Peak ... services for a healthy home and business in Colorado ... damage , mold inspections, mold testing, mold removal ... and coil cleaning. , With over 120 offices nationwide, ... industry offering a full suite of services for commercial, ...

Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2 Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2 Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3 Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4

[0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals [0] Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes [0] Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary [0] Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases [0] Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area

... Grants New Indication for Bothersome Vaginal Symptom Associated,With ... estrogens) Vaginal Cream 0.5 g has been approved ... a new indication and a new less,frequent twice-weekly ... (painful sexual intercourse) announced Wyeth,Pharmaceuticals, a division of ...

... from patients with lung cancer and examining them under ... utilized to better tailor the chemotherapy treatments to improve ... according to a study presented at the 2008 Chicago ... IASLC and the University of Chicago., Cancer researchers have ...

... tumors of African-American non-small cell lung cancer patients are ... of the epidermal growth factor receptor (EGFR) gene and ... a study presented at the 2008 Chicago Multidisciplinary Symposium ... the University of Chicago., These genetic factors have been ...

... are one milliard of a metre in size are ... materials. There are also significant amounts of nanoparticles in ... their health effects, because only a very small portion ... and safety risks. Nanoparticles have even been dubbed the ...

... http://www.HealthCentral.com ) the leading collection of condition-specific,consumer ... a,broad initiative to sell advertising for any ... partners on a,non-exclusive basis and not require ... party rankings., "We are changing the ...

... those shoppers who,wake up at 4am on Black Friday? Not ... is important not to disturb your circadian rhythm and to ... body,operates better on a good night,s sleep which is why ... the day after Thanksgiving.", SSA retailers nationwide have an ...

Cached Medicine News:Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 2 Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 3 Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 4 Health News:Research demonstrates differing genetic makeup of lung cancer in African-American patients 2 Health News:Nanoparticles trigger cell death? 2 Health News:HealthCentral Announces New Condition-Specific Ad Service to Offer Marketers the Highest Qualified Audiences 2 Health News:Don't Disturb Your Circadian Rhythm This Black Friday 'Sleep In, Nap Later,' says Specialty Sleep Association 2

FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse Tissue analyses indicate survival benefits for some lung cancer patients Research demonstrates differing genetic makeup of lung cancer in African-American patients Nanoparticles trigger cell death?HealthCentral Announces New Condition-Specific Ad Service to Offer Marketers the Highest Qualified Audiences Don't Disturb Your Circadian Rhythm This Black Friday 'Sleep In, Nap Later,' says Specialty Sleep Association

The K-ASSAY Fibrinogen Control is an assayed quality control material intended for use in monitoring the accuracy and precision of the quantitative determination of fibrinogen....

The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...

Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...

... Directigen EZ Flu A+B test is a ... qualitative detection of influenza A and B ... swabs of symptomatic patients. The Directigen EZ ... such that influenza A viral antigens can ...

Medicine Products:

Fibrinogen Control ASO Control Microcentrifuge Model 5418 Directigen EZ Flu A+B Test Kit